Unprecedented levels of immunosuppression in countries like Australia and the US must be considered in planning for the risk of smallpox re-emerging in the world, an expert in infectious diseases from the [Read more]
Researchers have developed a new non-human primate (NHP) animal model to study Crimean-Congo hemorrhagic fever (CCHF), a viral disease spread by ticks in the Middle East, Asia, Africa and parts of Europe. [Read more]
The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool’s power, and has developed a miniature paper test that allows results to [Read more]
The U.S. Centers for Disease Control and Prevention is seeking a vendor who can obtain anonymous pre- and post-immunization sera from specified age-groups of Europeans. The study must be conducted in a [Read more]
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Webinar, on Tuesday, March 20, 2018, at 12:30 PM ET, in support of the anticipated Biostasis [Read more]
Overt symptoms of many diseases often do not manifest until days after a person’s initial exposure to the causative pathogen, typically a virus or bacteria. By then, the disease may have progressed [Read more]
Scientists performed genetic sequencing of patient samples from the monkeypox virus (MXPV) outbreak in Nigeria, revealing that the outbreak likely originated from a source within the country. “Based on our findings, it [Read more]
A modeling study published last month in the Proceedings of the National Academies of Science suggests that human fleas and body lice–rather than rodents–may have caused a string of historical plague outbreaks [Read more]
Prior studies of survivors of the 2014-2016 Ebola outbreak in West Africa have revealed sexual transmission of Ebola virus, and that viral RNA (Ebola virus genetic material) can persist in semen following recovery. [Read more]
The American Society for Microbiology’s ASM Biothreats 2018 meeting is taking place February 12-14, 2018 in Baltimore, Maryland. ASM Biothreats includes tracks on high consequence pathogen research, biological threat reduction, product development, [Read more]
© 2018 Global Biodefense